Publicacións nas que colabora con MIGUEL ÁNGEL LÓPEZ NEVOT (45)

2022

  1. Incidence, Management Experience and Characteristics of Patients with Giardiasis and Common Variable Immunodeficiency

    Journal of Clinical Medicine, Vol. 11, Núm. 23

  2. Major Histocompatibility Complex Class I Chain-Related α (MICA) STR Polymorphisms in COVID-19 Patients

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

  3. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients

    Journal of Microbiology, Immunology and Infection, Vol. 55, Núm. 3, pp. 421-427

2021

  1. Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts

    Frontiers in Immunology, Vol. 12

2020

  1. Joint study of the associations of HLA-B and the transmembrane short tandem repeat polymorphism of MICA protein with alopecia areata shows independent associations of both with the disease

    Clinical and Experimental Dermatology, Vol. 45, Núm. 6, pp. 699-704

  2. NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Asymptomatic Leishmania infection in blood donors from the Southern of Spain

    Infection, Vol. 47, Núm. 5, pp. 739-747

  2. Familial frontal fibrosing alopecia: A cross-sectional study of 20 cases from nine families

    Australasian Journal of Dermatology, Vol. 60, Núm. 2, pp. e113-e118

  3. Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium

    Scientific Reports, Vol. 9, Núm. 1

  4. Study of Human Leukocyte Antigen (HLA) in 13 cases of familial frontal fibrosing alopecia: CYP21A2 gene p.V281L mutation from congenital adrenal hyperplasia linked to HLA class I haplotype HLA-A*33:01; B*14:02; C*08:02 as a genetic marker

    Australasian Journal of Dermatology, Vol. 60, Núm. 3, pp. e195-e200

2015

  1. Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: A multicenter study

    Pharmacogenetics and Genomics, Vol. 25, Núm. 7, pp. 323-333

2012

  1. Analysis of class II human leucocyte antigens in Italian and Spanish systemic sclerosis

    Rheumatology, Vol. 51, Núm. 1, pp. 52-59

2011

  1. Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin

    American Journal of Gastroenterology, Vol. 106, Núm. 7, pp. 1246-1254

2009

  1. Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus

    Human Molecular Genetics, Vol. 18, Núm. 19, pp. 3739-3748

  2. Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus

    Clinical and Experimental Rheumatology

  3. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans

    Journal of Clinical Investigation, Vol. 119, Núm. 4, pp. 911-923

  4. No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus

    Lupus, Vol. 18, Núm. 3, pp. 230-234

  5. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 11, pp. 1746-1753

2008

  1. Study of two polymorphisms of the MHC2TA gene with systemic lupus erythematosus [1]

    Rheumatology

2007

  1. Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus

    Tissue Antigens, Vol. 70, Núm. 3, pp. 233-237